Arthrobon PEA

Beyond chondroprotection: advanced neuromodulation, immune support, and superior bioavailability

For Dogs

ox with 60 highly palatable tablets
Clinic Box with 240 highly palatable tablets
Professional clinical kit for veterinary use only

Technical caracteristics

Arthrobon PEA provides a comprehensive 360° approach to managing canine osteoarthritis and osteoarthrosis. By understanding the disease not as an isolated event but as a complex and heterogeneous clinical syndrome, our formula acts simultaneously on low‑grade inflammation, extracellular matrix degradation (type II collagen and proteoglycans), and abnormal bone remodeling.

Thanks to the incorporation of PEA (palmitoylethanolamide) and high‑bioavailability technology, Arthrobon PEA not only preserves joint structure but also actively contributes to pain modulation and the patient’s functional recovery.

Presentation

60 / 240 palatable tablets.

Indications

  • Neuromodulation of pain: PEA. Chronic and neuropathic pain control via PPAR‑α receptors.

  • Inflammation modulation: phytosomal nanocurcumin. Stabilization of the joint microenvironment.

  • Joint immunomodulation: UC‑II. Interacts with Peyer’s patches in the intestine to deactivate the autoimmune response.

  • Bioregeneration: Ovacore + Mesoporosil. Accelerated cartilage repair.

Administration and dosage

Arthrobon PEA is administered orally. Thanks to its palatable tablet format, administration is effortless. It can also be given mixed with food.

Recommended dosage

Weight Diary dose
Less than 5 Kg ½ tablet
5,1 a 20 Kg 1 tablet
20,1 a 30 Kg 1 ½ tablet
30,1 a 50 Kg 2 tablets
More than 50 Kg 3 tablets

 

Conservation and precautions

  • Keep out of the reach and sight of children.
  • Store in a cool place protected from light.
  • This product contains egg derivatives.

Documents

You may also be interested in: